Skip to content

Medical-device intelligence

Quantimetrix Corp.: FDA clearances and recalls

Research Quantimetrix Corp. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

38 clearance records and 0 recall records in the covered releases, across 1 source company names and 18 product codes. Dated history runs from Apr 18, 1983 to Apr 10, 2015.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

38 matching records
Device / recordCompany in FDA recordSourceSource date
QUANTIMETRIX HUMAN BILIRUBIN CONTROL I & II LIQUIDK860942 · JJYQuantimetrix Corp.510(k)May 23, 1986FDA decision date
QUANTTEST TOTAL PROTEIN ASSAYK853932 · CEKQuantimetrix Corp.510(k)Dec 19, 1985FDA decision date
QUANTIMETRIX BIURET SERUM TOTAL PROTEIN ASSAY KITK853930 · CEKQuantimetrix Corp.510(k)Dec 10, 1985FDA decision date
QUANTIMETRIX HUMAN SERUM CHEMISTRY CONTROLK853931 · JJYQuantimetrix Corp.510(k)Oct 4, 1985FDA decision date
QUANTIMETRIX HUMAN SERUM THERAPEUTIC DRUG CONTROLK853933 · DIFQuantimetrix Corp.510(k)Oct 4, 1985FDA decision date
HUMAN SERUM ANTICONVULSANT DRUG CONTROLK843818 · DIFQuantimetrix Corp.510(k)Oct 30, 1984FDA decision date
HUMAN SERUM CARDIOACTIVE DRUG CONTROLK843679 · DIFQuantimetrix Corp.510(k)Oct 5, 1984FDA decision date
HUMAN SERUM ELECTROLYTE CONTROL-LIQUIDK834505 · JJRQuantimetrix Corp.510(k)Apr 13, 1984FDA decision date
ACETAMINOPHER ASSAY KITK832045 · LDPQuantimetrix Corp.510(k)Oct 4, 1983FDA decision date
URINE TOTAL PROTEIN CONTROLK831526 · JJWQuantimetrix Corp.510(k)Aug 12, 1983FDA decision date
SPINAL FLUID TOTAL PROTEIN CONTROLK831527 · JJXQuantimetrix Corp.510(k)Jul 18, 1983FDA decision date
SALICYLATE ASSAY KITK831336 · DKJQuantimetrix Corp.510(k)Jul 7, 1983FDA decision date
QUANTIMETRIX BROMERESOL PURPLE ALBUMINK830934 · CJWQuantimetrix Corp.510(k)Apr 18, 1983FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗